These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28429653)

  • 21. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
    Reynolds CP
    Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.
    Shibina A; Seidel D; Somanchi SS; Lee DA; Stermann A; Maurer BJ; Lode HN; Reynolds CP; Huebener N
    J Mol Med (Berl); 2013 Apr; 91(4):459-72. PubMed ID: 23052481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
    Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
    BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed micelles of TPGS and Soluplus
    Wang Y; Ding Y; Xu Y; Wang C; Ding Y; Gao M; Ma C; Ma X; Li L
    Pharm Dev Technol; 2020 Sep; 25(7):865-873. PubMed ID: 32266855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.
    Fang H; Harned TM; Kalous O; Maldonado V; DeClerck YA; Reynolds CP
    Clin Cancer Res; 2011 Nov; 17(22):7093-104. PubMed ID: 21933888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.
    Nguyen TH; Koneru B; Wei SJ; Chen WH; Makena MR; Urias E; Kang MH; Reynolds CP
    Mol Cancer Ther; 2019 Dec; 18(12):2270-2282. PubMed ID: 31484706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide.
    Rayburg M; Towbin A; Yin H; Maugans T; Maurer B; Nagarajan R; Weiss B
    Pediatr Blood Cancer; 2009 Dec; 53(6):1111-3. PubMed ID: 19621427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.
    Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Bogenmann E; Ponzoni M; Montaldo PG
    Cancer Lett; 2003 Jul; 197(1-2):151-5. PubMed ID: 12880975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.
    Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Montaldo PG; Gambini C; Allen TM; Bogenmann E; Ponzoni M
    Int J Cancer; 2003 May; 104(5):559-67. PubMed ID: 12594810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
    Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies.
    Boulter AC; Maurer BJ; Pogue M; Kang MH; Cho H; Knight A; Reynolds CP; Quick D; Awasthi S; Gerber DE
    Cancer Chemother Pharmacol; 2023 Aug; 92(2):97-105. PubMed ID: 37199745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.
    Makena MR; Cho HE; Nguyen TH; Koneru B; Verlekar DU; Hindle A; Kang MH; Reynolds CP
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27447. PubMed ID: 30251395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
    Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
    Oncol Rep; 2003; 10(5):1587-92. PubMed ID: 12883745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure.
    Cooper JP; Hwang K; Singh H; Wang D; Reynolds CP; Curley RW; Williams SC; Maurer BJ; Kang MH
    Br J Pharmacol; 2011 Jul; 163(6):1263-75. PubMed ID: 21391977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.
    Appierto V; Cavadini E; Pergolizzi R; Cleris L; Lotan R; Canevari S; Formelli F
    Br J Cancer; 2001 Jun; 84(11):1528-34. PubMed ID: 11384104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
    Conley B; O'Shaughnessy J; Prindiville S; Lawrence J; Chow C; Jones E; Merino MJ; Kaiser-Kupfer MI; Caruso RC; Podgor M; Goldspiel B; Venzon D; Danforth D; Wu S; Noone M; Goldstein J; Cowan KH; Zujewski J
    J Clin Oncol; 2000 Jan; 18(2):275-83. PubMed ID: 10637240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors.
    Otterson GA; Lavelle J; Villalona-Calero MA; Shah M; Wei X; Chan KK; Fischer B; Grever M
    Invest New Drugs; 2005 Dec; 23(6):555-62. PubMed ID: 16034523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenretinide-polyethylene glycol (PEG) conjugate with improved solubility enhanced cytotoxicity to cancer cell and potent
    Wang Y; Ding Y; Wang C; Gao M; Xu Y; Ma X; Ma X; Cui H; Li L
    Pharm Dev Technol; 2020 Oct; 25(8):962-970. PubMed ID: 32366203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.
    Ganeshan VR; Schor NF
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):271-9. PubMed ID: 24253178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.